← Browse by Condition
Medical Condition

myelofibroses

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT03326310 Phase 1
Recruiting

Selumetinib and Azacitidine in High Risk Chronic Blood Cancers

Enrollment
18 pts
Location
United States
Sponsor
University of Chicago
View Trial →